Dysplasia and cancer in inflammatory bowel disease

Robert J. Basseri, Benjamin Basseri, Konstantinos A. Papadakis

Research output: Contribution to journalReview articlepeer-review

15 Scopus citations


Inflammatory bowel disease (IBD) is a chronic gastrointestinal disease associated with an increased risk of colorectal cancer (CRC). Although CRC occurs in a minority of IBD patients (1%), it carries a high mortality and accounts for 20% of IBD-related mortality. Established risk factors for the development of CRC in IBD include disease duration of 8 years or more, family history of CRC, extensive colitis and primary sclerosing cholangitis. Meticulous colonoscopy and anti-inflammatory medications can reduce the risk of developing CRC. The future of IBD surveillance involves the use of novel endoscopic techniques (chromoendoscopy, narrow-band imaging, confocal laser endomicroscopy and autofluorescence) to enhance colonoscopic accuracy, in concert with chemopreventative medications to help reduce the risk of CRC in IBD.

Original languageEnglish (US)
Pages (from-to)59-66
Number of pages8
JournalExpert Review of Gastroenterology and Hepatology
Issue number1
StatePublished - Feb 2011


  • IBD
  • colorectal cancer
  • dysplasia
  • inflammatory bowel disease

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology


Dive into the research topics of 'Dysplasia and cancer in inflammatory bowel disease'. Together they form a unique fingerprint.

Cite this